8-144515239-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_004260.4(RECQL4):c.1394C>T(p.Thr465Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000207 in 1,593,190 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T465A) has been classified as Uncertain significance.
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Publications
- Baller-Gerold syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet
- Rothmund-Thomson syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Rothmund-Thomson syndrome type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- osteosarcomaInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- rapadilino syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004260.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RECQL4 | NM_004260.4 | MANE Select | c.1394C>T | p.Thr465Met | missense | Exon 8 of 21 | NP_004251.4 | ||
| RECQL4 | NM_001413043.1 | c.-74C>T | 5_prime_UTR_premature_start_codon_gain | Exon 6 of 19 | NP_001399972.1 | ||||
| RECQL4 | NM_001413019.1 | c.1394C>T | p.Thr465Met | missense | Exon 8 of 20 | NP_001399948.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RECQL4 | ENST00000617875.6 | TSL:1 MANE Select | c.1394C>T | p.Thr465Met | missense | Exon 8 of 21 | ENSP00000482313.2 | ||
| RECQL4 | ENST00000621189.4 | TSL:1 | c.323C>T | p.Thr108Met | missense | Exon 7 of 20 | ENSP00000483145.1 | ||
| RECQL4 | ENST00000532846.2 | TSL:5 | c.278C>T | p.Thr93Met | missense | Exon 4 of 9 | ENSP00000476551.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152218Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000231 AC: 5AN: 216364 AF XY: 0.0000255 show subpopulations
GnomAD4 exome AF: 0.0000201 AC: 29AN: 1440854Hom.: 0 Cov.: 33 AF XY: 0.0000224 AC XY: 16AN XY: 715098 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152336Hom.: 0 Cov.: 34 AF XY: 0.0000269 AC XY: 2AN XY: 74484 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The p.T465M variant (also known as c.1394C>T), located in coding exon 8 of the RECQL4 gene, results from a C to T substitution at nucleotide position 1394. The threonine at codon 465 is replaced by methionine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear.
not provided Uncertain:1
DNA sequence analysis of the RECQL4 gene demonstrated a sequence change, c.1394C>T, in exon 8 that results in an amino acid change, p.Thr465Met. This sequence change does not appear to have been previously described in individuals with RECQL4-related disorders. This sequence change has been described in the gnomAD database with a global frequency of 0.002% (dbSNP rs899474226). The p.Thr465Met change affects a highly conserved amino acid residue located in a domain of the RECQL4 protein that is not known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD) provide contradictory results for the p.Thr465Met substitution. Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Thr465Met change remains unknown at this time.
Baller-Gerold syndrome Uncertain:1
This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 465 of the RECQL4 protein (p.Thr465Met). This variant is present in population databases (no rsID available, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with RECQL4-related conditions. ClinVar contains an entry for this variant (Variation ID: 459322). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt RECQL4 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Hereditary cancer-predisposing syndrome Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at